More Articles Back to Article
FDA sends warning letter to Chinese OTC drug firm
The FDA sent a warning letter to Chinese OTC drug firm Huaian Zongheng Bio-Tech after finding out the company's Huaian, China, plant sent OTC drugs to the US without testing the ingredients or retaining samples of the final products to see if they comply with specifications. FiercePharma (1/15)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!